Gold nanoparticles in delivery applications

Advanced Drug Delivery Reviews

Volumn 60, Issue 11, 2008, Pages 1307-1315

  Ghosh, Partha ^a   Han, Gang ^a   De, Mrinmoy ^a   Kim, Chae Kyu ^a   Rotello, Vincent M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Delivery; DNA; Drug delivery; Glutathione; Gold; Nanoparticles; Photochemistry; Release; Self assembled monolayer

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; GENE TRANSFER; GOLD; NANOPARTICLES; NANOSTRUCTURES; SURFACE CHARGE; SURFACE PROPERTIES;

(1 1 0) SURFACE; (PL) PROPERTIES; ELSEVIER (CO); GENE DELIVERY; GOLD NANOPARTICLES (NANO-AU);

NANOSTRUCTURED MATERIALS;

GLUTATHIONE; GOLD NANOPARTICLE; MACROGOL; METAL NANOPARTICLE; NITRIC OXIDE; SINGLET OXYGEN; THIOL DERIVATIVE;

CELL METABOLISM; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TARGETING; FLUORESCENCE; GENE TARGETING; HUMAN; HYDROPHOBICITY; IN VIVO STUDY; MOLECULAR INTERACTION; MONOLAYER CULTURE; NONHUMAN; PHOTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; THERMAL ANALYSIS;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; GOLD; HUMANS; METAL NANOPARTICLES; SULFHYDRYL COMPOUNDS; TEMPERATURE;

EID: 46749122210     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.03.016     Document Type: Review

References (78)

1. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev., Cancer 5 (2005) 161-171
2. Xu P.S., Van Kirk E.A., Zhan Y.H., Murdoch W.J., Radosz M., and Shen Y.Q. Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew. Chem., Int. Ed. 46 (2007) 4999-5002
3. Paleos C.M., Tsiourvas D., Sideratou Z., and Tziveleka L. Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system. Biomacromolecules 5 (2004) 524-529
4. Kisak E.T., Coldren B., Evans C.A., Boyer C., and Zasadzinski J.A. The vesosome - a multicompartment drug delivery vehicle. Curr. Med. Chem. 11 (2004) 199-219
5. Wu W., Wieckowski S., Pastorin G., Benincasa M., Klumpp C., Briand J.P., Gennaro R., Prato M., and Bianco A. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew. Chem., Int. Ed. 44 (2005) 6358-6362
6. Salem A.K., Searson P.C., and Leong K.W. Multifunctional nanorods for gene delivery. Nat. Mater. 2 (2003) 668-671
7. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., and Tamarkin L. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11 (2004) 169-183
8. Paciotti G.F., Kingston D.G.I., and Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Dev. Res. 67 (2006) 47-54
9. Hong R., Han G., Fernandez J.M., Kim B.J., Forbes N.S., and Rotello V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 128 (2006) 1078-1079
10. Polizzi M.A., Stasko N.A., and Schoenfisch M.H. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir 23 (2007) 4938-4943
11. Han G., You C.C., Kim B.J., Turingan R.S., Forbes N.S., Martin C.T., and Rotello V.M. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. Angew. Chem., Int. Ed. 45 (2006) 3165-3169
12. Connor E.E., Mwamuka J., Gole A., Murphy C.J., and Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1 (2005) 325-327
13. Skirtach A.G., Javier A.M., Kreft O., Kohler K., Alberola A.P., Mohwald H., Parak W.J., and Sukhorukov G.B. Laser-induced release of encapsulated materials inside living cells. Angew. Chem. Int. Ed. 45 (2006) 4612-4617
14. Cheng M.M.C., Cuda G., Bunimovich Y.L., Gaspari M., Heath J.R., Hill H.D., Mirkin C.A., Nijdam A.J., Terracciano R., Thundat T., and Ferrari M. Nanotechnologies for biomolecular detection and medical diagnostics. Curr. Opin. Chem. Biol. 10 (2006) 11-19
15. Rosi N.L., and Mirkin C.A. Nanostructures in biodiagnostics. Chem. Rev. 105 (2005) 1547-1562
16. Schmid G. Large clusters and colloids - metals in the embryonic state. Chem. Rev. 92 (1992) 1709-1727
17. Brust M., Walker M., Bethell D., Schiffrin D.J., and Whyman R. Synthesis of thiol-derivatized gold nanoparticles in a 2-phase liquid-liquid system. J. Chem. Soc., Chem. Commun. (1994) 801-802
18. Templeton A.C., Wuelfing M.P., and Murray R.W. Monolayer protected cluster molecules. Acc. Chem. Res. 33 (2000) 27-36
19. Grabar K.C., Freeman R.G., Hommer M.B., and Natan M.J. Preparation and characterization of Au colloid monolayers. Anal. Chem. 67 (1995) 735-743
20. Frens G. Controlled nucleation for regulation of particle-size in monodisperse gold suspensions. Nature Phys. Sci. 241 (1973) 20-22
21. Turkevich J., Stevenson P.C., and Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold, discuss. Faraday Soc. (1951) 55-57
22. Fan J., Chen S.W., and Gao Y. Coating gold nanoparticles with peptide molecules via a peptide elongation approach. Colloids Surf., B Biointerfaces 28 (2003) 199-207
23. Otsuka H., Nagasaki Y., and Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 55 (2003) 403-419
24. Takae S., Akiyama Y., Otsuka H., Nakamura T., Nagasaki Y., and Kataoka K. Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA(120) lectin with lactose installed to the distal end of tethered PEG strands on gold surface. Biomacromolecules 6 (2005) 818-824
25. Otsuka H., Akiyama Y., Nagasaki Y., and Kataoka K. Quantitative and reversible lectin-induced association of gold nanoparticles modified with alpha-lactosyl-omega-mercapto-poly(ethylene glycol). J. Am. Chem. Soc. 123 (2001) 8226-8230
26. Ishii T., Otsuka H., Kataoka K., and Nagasaki Y. Preparation of functionally PEGylated gold nanoparticles with narrow distribution through autoreduction of auric cation by alpha-biotinyl-PEG-block-[poly(2-(N,N-dimethylamino)ethyl methacrylate)]. Langmuir 20 (2004) 561-564
27. Khalil H., Mahajan D., Rafailovich M., Gelfer M., and Pandya K. Synthesis of zerovalent nanophase metal particles stabilized with poly(ethylene glycol). Langmuir 20 (2004) 6896-6903
28. Shimmin R.G., Schoch A.B., and Braun P.V. Polymer size and concentration effects on the size of gold nanoparticles capped by polymeric thiols. Langmuir 20 (2004) 5613-5620
29. Tshikhudo T.R., Wang Z., and Brust M. Biocompatible gold nanoparticles. Mater. Sci. Technol. 20 (2004) 980-984
30. Olivier J.C., Huertas R., Lee H.J., Calon F., and Pardridge W.M. Synthesis of pegylated immunonanoparticles. Pharm. Res. 19 (2002) 1137-1143
31. Hostetler M.J., Wingate J.E., Zhong C.J., Harris J.E., Vachet R.W., Clark M.R., Londono J.D., Green S.J., Stokes J.J., Wignall G.D., Glish G.L., Porter M.D., Evans N.D., and Murray R.W. Alkanethiolate gold cluster molecules with core diameters from 1.5 to 5.2 nm: core and monolayer properties as a function of core size. Langmuir 14 (1998) 17-30
32. Gibson J.D., Khanal B.P., and Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. J. Am. Chem. Soc. 129 (2007) 11653-11661
33. Anderson M.E. Glutathione: an overview of biosynthesis and modulation. Chem.-Biol. Interact. 112 (1998) 1-14
34. Sies H. Glutathione and its role in cellular functions. Free Radic. Biol. Med. 27 (1999) 916-921
35. Jones D.P., Carlson J.L., Mody V.C., Cai J.Y., Lynn M.J., and Sternberg P. Redox state of glutathione in human plasma. Free Radic. Biol. Med. 28 (2000) 625-635
36. Jones D.P., Carlson J.L., Samiec P.S., Sternberg P., Mody V.C., Reed R.L., and Brown L.A.S. Glutathione measurement in human plasma evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta 275 (1998) 175-184
37. Saito G., Swanson J.A., and Lee K.D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. 55 (2003) 199-215
38. Huang S.Y., Shahriarm P.Y., Wang J.H., Choudhury I., Leibowitz M.J., and Stein S. A polyethylene glycol copolymer for carrying and releasing multiple copies of cysteine-containing peptides. Bioconjug. Chem. 9 (1998) 612-617
39. Weerapreeyakul N., Hollenbeck R.G., and Chikhale P.J. Stability of bioreductive drug delivery systems containing melphalan is influenced by conformational constraint and electronic properties of substituents. Bioorg. Med. Chem. Lett. 10 (2000) 2391-2395
40. Shen W.C., Ryser H.J.P., and Lamanna L. Disulfide spacer between methotrexate and poly(d-lysine) - a probe for exploring the reductive process in endocytosis. J. Biol. Chem. 260 (1985) 905-908
41. Bernkop-Schnurch A., Guggi D., and Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Control. Release 94 (2004) 177-186
42. Gunnarsdottir S., Rucki M., and Elfarra A.A. Novel glutathione-dependent thiopurine prodrugs: evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice. J. Pharm. Exp. Ther. 301 (2002) 77-86
43. Sapsford K.E., Berti L., and Medintz I.L. Materials for fluorescence resonance energy transfer analysis: beyond traditional donor-acceptor combinations. Angew. Chem., Int. Ed. 45 (2006) 4562-4588
44. Dulkeith E., Morteani A.C., Niedereichholz T., Klar T.A., Feldmann J., Levi S.A., van Veggel F.C.J.M., Reinhoudt D.N., Moller M., and Gittins D.I. Fluorescence quenching of dye molecules near gold nanoparticles: radiative and nonradiative effects. Phys. Rev. Lett. 89 (2002) 203002
45. Weishaupt K.R., Gomer C.J., and Dougherty T.J. Identification of singlet oxygen as cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 36 (1976) 2326-2329
46. Hone D.C., Walker P.I., Evans-Gowing R., FitzGerald S., Beeby A., Chambrier I., Cook M.J., and Russell D.A. Generation of cytotoxic singlet oxygen via phthalocyanine-stabilized gold nanoparticles: a potential delivery vehicle for photodynamic therapy. Langmuir 18 (2002) 2985-2987
47. Mocellin S., Bronte V., and Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med. Res. Rev. 27 (2007) 317-352
48. Mellman I., Fuchs R., and Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55 (1986) 663-700
49. Engin K., Leeper D.B., Cater J.R., Thistlethwaite A.J., Tupchong L., and Mcfarlane J.D. Extracellular pH distribution in human tumors. Int. J. Hypertherm. 11 (1995) 211-216
50. Yang Q., Wang S.H., Fan P.W., Wang L.F., Di Y., Lin K.F., and Xiao F.S. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem. Mater. 17 (2005) 5999-6003
51. Miller A.D. Human gene-therapy comes of age. Nature 357 (1992) 455-460
52. Yeh P., and Perricaudet M. Advances in adenoviral vectors: from genetic engineering to their biology. Faseb J. 11 (1997) 615-623
53. Check E. Gene therapy: a tragic setback. Nature 420 (2002) 116-118
54. Wiethoff C.M., and Middaugh C.R. Barriers to nonviral gene delivery. J. Pharm. Sci. 92 (2003) 203-217
55. Thomas M., and Klibanov A.M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 62 (2003) 27-34
56. McIntosh C.M., Esposito E.A., Boal A.K., Simard J.M., Martin C.T., and Rotello V.M. Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters. J. Am. Chem. Soc. 123 (2001) 7626-7629
57. Han G., Martin C.T., and Rotello V.M. Stability of gold nanoparticle-bound DNA toward biological, physical, and chemical agents. Chem. Biol. Drug Des. 67 (2006) 78-82
58. Han G., Chari N.S., Verma A., Hong R., Martin C.T., and Rotello V.M. Controlled recovery of the transcription of nanoparticle-bound DNA by intracellular concentrations of glutathione. Bioconjug. Chem. 16 (2005) 1356-1359
59. Sandhu K.K., McIntosh C.M., Simard J.M., Smith S.W., and Rotello V.M. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjug. Chem. 13 (2002) 3-6
60. Thomas M., and Klibanov A.M. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9138-9143
61. Wang H., Chen Y., Li X.Y., and Liu Y. Synthesis of oligo(ethylenediamino)-beta-cyclodextrin modified gold nanoparticle as a DNA concentrator. Mol. Pharm. 4 (2007) 189-198
62. Oishi M., Nakaogami J., Ishii T., and Nagasaki Y. Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem. Lett. 35 (2006) 1046-1047
63. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K.R., Han M.S., and Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312 (2006) 1027-1030
64. Giljohann D.A., Seferos D.S., Patel P.C., Millstone J.E., Rosi N.L., and Mirkin C.A. Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett. 7 (2007) 3818-3821
65. Verma A., Simard J.M., Worrall J.W.E., and Rotello V.M. Tunable reactivation of nanoparticle-inhibited beta-galactosidase by glutathione at intracellular concentrations. J. Am. Chem. Soc. 126 (2004) 13987-13991
66. Bhumkar D.R., Joshi H.M., Sastry M., and Pokharkar V.B. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm. Res. 24 (2007) 1415-1426
67. Jain P.K., El-Sayed I.H., and El-Sayed M.A. Au nanoparticles target cancer. Nano Today 2 (2007) 18-29
68. Huang X., Qian W., El-Sayed I.H., and El-Sayed M.A. The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy. Laser Surg. Med. 39 (2007) 747-753
69. Angelatos A.S., Radt B., and Caruso F. Light-responsive polyelectrolyte/gold nanoparticle microcapsules. J. Phys. Chem., B 109 (2005) 3071-3076
70. Brannon-Peppas L., and Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliver. Rev. 56 (2004) 1649-1659
71. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54 (2002) 631-651
72. Baban D.F., and Seymour L.W. Control of tumour vascular permeability. Adv. Drug Deliv. Rev. 34 (1998) 109-119
73. Bergen J.M., Von Recum H.A., Goodman T.T., Massey A.P., and Pun S.H. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol. Biosci. 6 (2006) 506-516
74. Chithrani B.D., Ghazani A.A., and Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano. Lett. 6 (2006) 662-668
75. Chithrani B.D., and Chan W.C.W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano. Lett. 7 (2007) 1542-1550
76. Dixit V., Van den Bossche J., Sherman D.M., Thompson D.H., and Andres R.P. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug. Chem. 17 (2006) 603-609
77. Chen Y.H., Tsai C.Y., Huang P.Y., Chang M.Y., Cheng P.C., Chou C.H., Chen D.H., Wang C.R., Shiau A.L., and Wu C.L. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol. Pharm. 4 (2007) 713-722
78. de la Fuente J.M., and Berry C.C. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug. Chem. 16 (2005) 1176-1180